期刊文献+

糖尿病视网膜病变患者血浆血栓调节蛋白和D-二聚体水平的研究 被引量:11

The changes of plasma thrombomodulin and D-Dimer(D-D)level in patients with diabetic retinopathy
原文传递
导出
摘要 目的探讨血栓调节蛋白(TM)和D-二聚体(D-D)与DR的关系。方法将60例糖尿病患者按眼底视网膜病变程度分为糖尿病无视网膜病变期(NDR),单纯型糖尿病视网膜病变期(SDR)和增殖型糖尿病视网膜病变期(PDR)。另选健康者30名作为正常对照(NC)组。测定各组血浆TM浓度及D-D浓度,同时研究TM与D-D的相关性。结果 (1)NDR、SDR和PDR组血浆TM水平[(27.17±18.30)、(39.67±18.41)和(61.83±24.31)ng/ml]均高于NC组[(15.63±13.79)ng/ml](P<0.05);(2)NDR组血浆D-D水平[(0.19±0.07)μg/ml]与NC组[(0.17±0.06)μg/ml]比较,差异无统计学意义(P>0.05);SDR、PDR组[(0.24±0.06)、(0.57±0.09)μg/ml]均高于NDR组与NC组(P<0.05);(3)血浆TM与D-D呈正相关(r=0.508,P<0.01)。结论检测血浆TM及D-D水平可帮助评价糖尿病患者血管内皮细胞损伤的情况,以及眼底视网膜病变程度,同时可反映体内是否存在高凝状态。 Objective To study the changes of plasma thrombomodulin and D-Dimer(D-D) level in patients with diabetic retinopathy. Methods 60 diabetic patients were divided into three groups: no diabetic retinopathy (NDR) group, simple diabetic retinopathy (SDR) group, and proliferative diabetic retinopathy(PDR) group. And 30 normal persons were also recruited as the control group. The plasma levels of TM and D-D were examined, and relationship between TM and DD was also investigated. Results (1) The plasma TM levels were higher in NDR group [(27.17 ±18.30)ng/ml'], SDR group [(39.67±18. 41)ng/ml],PDR group[-(61.8±24. 31)ng/ml] than in control group[(15.63±3. 79) ng/ml ] (P〈0.05) . The plasma TM level was higher in PDR group than in SDR and NDR groups(P〈0.05). (2) There was no statistical difference in D-D between NDR group[(0.19±0.07) μg/ml ] and control group[(0.17±0.06) μg/ml]. The plasma D-D levels were higher in PDR group[(0.57±0.09)μg/ml ] and SDR group[(0.24±0; 06) 〉g/ml] than in NDR and control groups, and it was also higher in PDR group than in SDR group(P〈0. 05). (3)TM level was positively correlated with D-D level(r= 0. 508, P〈0.01). Conclusion Clinical determination of plasma TM and D-Dimer level can help evaluate diabetic vascular endothelial cell injury and degree of fundus retinopathy, and reflect the presence of high coagulation state in the body at the same time.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2014年第3期224-226,共3页 Chinese Journal of Diabetes
基金 包头市社会发展科技支撑项目(2012S2006-04-04)
关键词 糖尿病视网膜病变 血栓调节蛋白 D-二聚体 Diabetic retinopathy~ Thrombomodulin~ I^Dimer
  • 相关文献

参考文献9

  • 1向光大.关注高血糖与血管内皮功能异常的关系[J].中国糖尿病杂志,2007,15(12):705-707. 被引量:13
  • 2Tang XL,Cai SY, Zhang RB,et al. Significance of plasma solvrble thrombomodulin in type 2 diabetic patients. Chin J Endocri-nol Metab,2005,21:316-317.
  • 3Coban E,Sari R,Ozdogan M,et al. Levels of plasm a fibrinogenand d-dimmer in patients with inpaired fasting glucose. ExpClin Endocrinol Diabetes .2005,113 : 35-37.
  • 4Erem C, Hacihasanoglu A,Celik S, et al. Coagulation and fibri-nolysis param sters in type 2 diabetic patients with and withoutdiabetic vascular complications. Med Prine pract, 2005, 14:22-30.
  • 5Aso Y,Fujiwara Y,Tayama K,et al. Relationship between sol-uble thrombomodulin in plasma and coagulation or fibrinolysisin type 2 diabetes. Clin Chim Acta. 2000,301 : 135-145.
  • 6Rigla M,Mateo J,Fontcuberta J,et al. Normalisation of tissuefactor pathway inhibitor activity after glycaemic control optimi-zation in type 1 diabetic patients. Thromb Haemost,2000,84:223-227.
  • 7Coban E, SariRt Ozdogan M,et al. Levels of plasm a fibrinogenand d-dimmer in patients with inpaired fasting glucose. ExpClin Endocrinol Diabetes, 2005,113: 35-37.
  • 8Erem C, Hacihasanoglu A,Celik S, et al,Coagulation and fibri-nolysis param sters in type 2 diabetic patients with and withoutdiabetic vascular complications. Med Prine pract, 2005, 14:22-30.
  • 9周卫平.2型糖尿病视网膜病变纤维蛋白原、D—二聚体和超敏C反应蛋白检测价值[J].南通大学学报(医学版),2009,29(1):22-24. 被引量:18

二级参考文献7

共引文献27

同被引文献136

引证文献11

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部